Primary Site >> Colorectal Cancer
Gene >> EREG
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. PMID: 11156386 |
Ref: Canonical WNT signaling pathway and human AREG. PMID: 16685431 |
Ref: Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab. PMID: 19738126 |
Ref: Prediction of liver metastasis after colorectal cancer using reverse transcription-polymerase chain reaction analysis of 10 genes. PMID: 20570135 Ref: Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics. PMID: 20631481 |
Ref: Impact of KRAS, BRAF, PIK3CA mutations, PTEN, AREG, EREG expression and skin rash in >/= 2 line cetuximab-based therapy of colorectal cancer patients. PMID: 21283802 |
Ref: Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases. PMID: 22409860 |
Ref: Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes. PMID: 23374602 Ref: Tumor fibroblast-derived epiregulin promotes growth of colitis-associated neoplasms through ERK. PMID: 23549083 Ref: [Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue]. PMID: 23885463 Ref: The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab. PMID: 24050852 |
Ref: Intergenic polymorphisms in the amphiregulin gene region as biomarkers in metastatic colorectal cancer patients treated with anti-EGFR plus irinotecan. PMID: 23959273 Ref: Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer. PMID: 24335920 |
Ref: Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer. PMID: 26867820 Ref: AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab: A Fresh Approach to an Old Puzzle. PMID: 26869404 Ref: Downregulation of epidermal growth factor receptor family receptors and ligands in a mutant K-ras group of patients with colorectal cancer. PMID: 26935861 Ref: Integrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoter. PMID: 27270421 Ref: Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. PMID: 27272216 Ref: PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study. PMID: 27296289 Ref: Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients. PMID: 27344184 |
Ref: Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial. PMID: 27681944 Ref: MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis. PMID: 28686677 Ref: [Mechanism of cross talk between tissue factor/active coagulation factor VII and epidermal growth factor receptor signalings in colon cancer cells in culture]. PMID: 29263461 |
Ref: Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer. PMID: 29075780 Ref: microRNA-451a regulates colorectal cancer proliferation in response to radiation. PMID: 29720118 Ref: Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data. PMID: 30016783 Ref: Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer. PMID: 30252132 |